Montreal’s public health department is warning parents and teenagers about a fake cough syrup in circulation that’s laced with a highly addictive opioid and a depressant that can cause overdose deaths ...

Indian pharma group Wockhardt has completed a pre-filing meeting with the FDA and hopes to submit its new antibiotic Zaynich in the US and Europe later this year, eyeing a possible launch in fiscal ...

Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are ...

Explore list of mutual funds that have invested in & analyse the ownership details to gain insights. Tata India Pharma & Healthcare Fund Regular Growth NA 3.27 40.28 HDFC Pharma and Healthcare Fund ...

Habil F Khorakiwala, Founder Chairman of Wockhardt Group, estimates the Indian market potential for its new antibiotic Foviscu or WCK 4282 at over ₹1,000 crore. The opportunity is driven by a large ...

Wockhardt announced that its novel intravenous antibiotic Foviscu (WCK 4282) has successfully met the primary endpoint in a Phase 3 clinical trial in patients with complicated urinary tract infections ...